206 related articles for article (PubMed ID: 19597921)
1. Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.
Davatchi F; Sadeghi Abdollahi B; Tehrani Banihashemi A; Shahram F; Nadji A; Shams H; Chams-Davatchi C
Mod Rheumatol; 2009; 19(5):542-9. PubMed ID: 19597921
[TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of colchicine in Behçet's syndrome.
Yurdakul S; Mat C; Tüzün Y; Ozyazgan Y; Hamuryudan V; Uysal O; Senocak M; Yazici H
Arthritis Rheum; 2001 Nov; 44(11):2686-92. PubMed ID: 11710724
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for Behcet's syndrome.
Saenz A; Ausejo M; Shea B; Wells G; Welch V; Tugwell P
Cochrane Database Syst Rev; 2000; 1998(2):CD001084. PubMed ID: 10796413
[TBL] [Abstract][Full Text] [Related]
4. Colchicine in the treatment of the cutaneous manifestations of Behçet's disease.
Miyachi Y; Taniguchi S; Ozaki M; Horio T
Br J Dermatol; 1981 Jan; 104(1):67-9. PubMed ID: 7459271
[TBL] [Abstract][Full Text] [Related]
5. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
Masuda K; Nakajima A; Urayama A; Nakae K; Kogure M; Inaba G
Lancet; 1989 May; 1(8647):1093-6. PubMed ID: 2566048
[TBL] [Abstract][Full Text] [Related]
6. Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Sharquie KE; Najim RA; Abu-Raghif AR
J Dermatol; 2002 May; 29(5):267-79. PubMed ID: 12081158
[TBL] [Abstract][Full Text] [Related]
7. Prolactin levels in Behçet's disease: no correlation with disease manifestations and activity.
Houman H; Ben Ghorbel I; Lamloum M; Feki M; Khanfir M; Mebazaa A; Miled M
Ann Med Interne (Paris); 2001 Apr; 152(3):209-11. PubMed ID: 11431583
[TBL] [Abstract][Full Text] [Related]
8. Comparison of existing disease activity indices in the follow-up of patients with Behçet's disease.
Shahram F; Khabbazi A; Nadji A; Ziaie N; Banihashemi AT; Davatchi F
Mod Rheumatol; 2009; 19(5):536-41. PubMed ID: 19590934
[TBL] [Abstract][Full Text] [Related]
9. Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease.
Calgüneri M; Ertenli I; Kiraz S; Erman M; Celik I
Dermatology; 1996; 192(2):125-8. PubMed ID: 8829493
[TBL] [Abstract][Full Text] [Related]
10. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
Saricaoglu H; Yilmaz M; Karkucak M; Ozturk HZ; Yakut T; Gulten T; Baskan EB; Aydogan K; Dilek K
Genet Mol Res; 2011 Jan; 10(1):1-6. PubMed ID: 21218380
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic constipation with colchicine: randomized, double-blind, placebo-controlled, crossover trial.
Verne GN; Davis RH; Robinson ME; Gordon JM; Eaker EY; Sninksy CA
Am J Gastroenterol; 2003 May; 98(5):1112-6. PubMed ID: 12809836
[TBL] [Abstract][Full Text] [Related]
12. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
Takeuchi M; Asukata Y; Kawagoe T; Ito N; Nishide T; Mizuki N
Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trial.
Faghfouri AH; Khabbazi A; Baradaran B; Khajebishak Y; Baghbani E; Noorolyai S; Rahmani S; Seyyed Shoura SM; Alipour M; Alipour B
Clin Nutr; 2022 May; 41(5):1083-1092. PubMed ID: 35413570
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
Ataş H; Cemil BC; Canpolat F; Gönül M
Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
[TBL] [Abstract][Full Text] [Related]
15. A double-blind trial of depot corticosteroids in Behçet's syndrome.
Mat C; Yurdakul S; Uysal S; Gogus F; Ozyazgan Y; Uysal O; Fresko I; Yazici H
Rheumatology (Oxford); 2006 Mar; 45(3):348-52. PubMed ID: 16263779
[TBL] [Abstract][Full Text] [Related]
16. Oral zinc sulfate in the treatment of Behcet's disease: a double blind cross-over study.
Sharquie KE; Najim RA; Al-Dori WS; Al-Hayani RK
J Dermatol; 2006 Aug; 33(8):541-6. PubMed ID: 16923135
[TBL] [Abstract][Full Text] [Related]
17. A double blind study of colchicine in Behçet's disease.
Aktulga E; Altaç M; Müftüoglu A; Ozyazgan Y; Pazarli H; Tüzün Y; Yalçin B; Yazici H; Yurdakul S
Haematologica; 1980 Jun; 65(3):399-402. PubMed ID: 6778795
[No Abstract] [Full Text] [Related]
18. Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.
Hatemi G; Melikoglu M; Tunc R; Korkmaz C; Turgut Ozturk B; Mat C; Merkel PA; Calamia KT; Liu Z; Pineda L; Stevens RM; Yazici H; Yazici Y
N Engl J Med; 2015 Apr; 372(16):1510-8. PubMed ID: 25875256
[TBL] [Abstract][Full Text] [Related]
19. Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial.
Hamuryudan V; Hatemi G; Tascilar K; Yurdakul S; Mat C; Ozyazgan Y; Seyahi E; Ugurlu S; Yazici H
J Rheumatol; 2014 Apr; 41(4):735-8. PubMed ID: 24532830
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of aphthosis with thalidomide and with colchicine].
Genvo MF; Faure M; Thivolet J
Dermatologica; 1984; 168(4):182-8. PubMed ID: 6724071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
